RxDoctor Payments Data

Amaan Haq, MD

Family Medicine · Detroit, MINPI 1275853269

Payments from drug & device makers

$1,084in general payments, 2019–2025

Across 59 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$234
  • Novartis$206
  • GSK$148
  • Exact Sciences$116
  • Lilly USA, LLC$98
  • Novo Nordisk$79
  • plus $203 from 8 others

What the payments were for

  • Food & beverage$1,084100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,084 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$78,835
Medicare patients
194
Services billed
1,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter292$218,784
TrulicityDulaglutide145$136,411
OzempicSemaglutide101$97,499
EliquisApixaban96$97,269
JardianceEmpagliflozin75$86,701
Metformin Er GastricMetformin Hcl13$38,530
EntrestoSacubitril/Valsartan30$37,791
XareltoRivaroxaban39$34,659
FarxigaDapagliflozin Propanediol35$27,808
MounjaroTirzepatide24$23,525
TradjentaLinagliptin25$20,726
JanuviaSitagliptin Phosphate23$19,059
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$12,781
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$10,354
InvokanaCanagliflozin11$10,316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$148$224,540307 claims
Lilly USA, LLCTrulicity, Mounjaro$98$159,935169 claims
Novo NordiskOzempic$79$97,499101 claims
PfizerEliquis$28$97,26996 claims
AstraZenecaFarxiga, Breztri Aerosphere$234$40,58956 claims
NovartisEntresto$206$37,79130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →